Exploration of Drug Science

Open Access Short Communication

FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management

Muhammad Mazhar Azam ... Bibek Giri

Published: December 03, 2024 Explor Drug Sci. 2024;2:867–874

DOI: https://doi.org/10.37349/eds.2024.00078

Full Text PDF

50053 275 12

Open Access Review

Sirtuin activators as an anti-aging intervention for longevity

Puja Sah ... Donkupar Syiem

Published: January 12, 2025 Explor Drug Sci. 2025;3:100881

DOI: https://doi.org/10.37349/eds.2025.100881

Full Text PDF

47044 516 18

Open Access Review

A review of the effects of pharmaceutical pollutants on humans and aquatic ecosystem

Jaya Vinny Eapen ... Jayesh Antony

Published: August 28, 2024 Explor Drug Sci. 2024;2:484–507

DOI: https://doi.org/10.37349/eds.2024.00058

Full Text PDF

41206 827 89

Open Access Perspective

Clinical studies with drugs and biologics aimed at slowing or reversing normal aging processes—emerging results and future perspectives

Ricardo P. Garay

Published: April 10, 2024 Explor Drug Sci. 2024;2:144–153

DOI: https://doi.org/10.37349/eds.2024.00040

Full Text PDF

35475 94 4

Open Access Review

Mechanisms of action and health benefits of probiotics: a comprehensive review

Seemi Tasnim Alam ... Md. Aftab Uddin

Published: September 17, 2025 Explor Drug Sci. 2025;3:1008129

DOI: https://doi.org/10.37349/eds.2025.1008129

Full Text PDF

32192 534 9

Open Access Review

Approved antibacterial drugs in the last 10 years: from the bench to the clinic

Miguel García-Castro ... Juan Manuel López-Romero

Published: June 30, 2023 Explor Drug Sci. 2023;1:180–209

DOI: https://doi.org/10.37349/eds.2023.00013

This article belongs to the special issue Exploring Potential Drugs from Natural Products

Full Text PDF

31694 567 22

Open Access Review

Nature-inspired and medicinally relevant short peptides

Maria G. Ciulla ... Kamal Kumar

Published: June 27, 2023 Explor Drug Sci. 2023;1:140–171

DOI: https://doi.org/10.37349/eds.2023.00011

This article belongs to the special issue Exploring Potential Drugs from Natural Products

Full Text PDF

30500 443 25

Open Access Review

Tirzepatide in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a novel star on the horizon?

Amedeo Lonardo, Ralf Weiskirchen

Published: September 04, 2025 Explor Drug Sci. 2025;3:1008128

DOI: https://doi.org/10.37349/eds.2025.1008128

Full Text PDF

27397 292 5

Open Access Review

Revisiting 3₁₀-helices: biological relevance, mimetics and applications

Diego Núñez-Villanueva

Published: February 01, 2024 Explor Drug Sci. 2024;2:6–37

DOI: https://doi.org/10.37349/eds.2024.00034

Full Text PDF

26514 323 12

Open Access Review

Seaweed: a sustainable solution for greening drug manufacturing in the pursuit of sustainable healthcare

Leonel Pereira, João Cotas

Published: February 27, 2024 Explor Drug Sci. 2024;2:50–84

DOI: https://doi.org/10.37349/eds.2024.00036

Full Text PDF

26422 366 49

Open Access Review

A narrative review on the role of gut microbiome, dietary strategies, and supplements in managing metabolic syndrome

Sunil Chopra ... Ramendra Pati Pandey

Published: April 14, 2025 Explor Drug Sci. 2025;3:1008105

DOI: https://doi.org/10.37349/eds.2025.1008105

Full Text PDF

25762 293 5

Open Access Review

Stapled peptides: targeting protein-protein interactions in drug development

Qian Zhang ... Chunqiu Zhang

Published: April 18, 2024 Explor Drug Sci. 2024;2:154–189

DOI: https://doi.org/10.37349/eds.2024.00041

This article belongs to the special issue Bioactive Peptides discovery and development

Full Text PDF

24576 352 15

Open Access Review

Antioxidants from microalgae and their potential impact on human well-being

Leonel Pereira ... Ana Valado

Published: May 31, 2024 Explor Drug Sci. 2024;2:292–321

DOI: https://doi.org/10.37349/eds.2024.00048

Full Text PDF

24040 458 46

Open Access Review

What are biopharmaceuticals?

Abhay H. Pande ... J. Anakha

Published: January 10, 2025 Explor Drug Sci. 2025;3:100880

DOI: https://doi.org/10.37349/eds.2025.100880

Full Text PDF

21352 433 3

Open Access Perspective

Resmetirom and semaglutide in metabolic dysfunction-associated steatohepatitis (MASH): a comparative perspective

Ralf Weiskirchen

Published: October 30, 2025 Explor Drug Sci. 2025;3:1008132

DOI: https://doi.org/10.37349/eds.2025.1008132

This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology

Full Text PDF

20466 312 7

Open Access Review

Combating antibiotic resistance: mechanisms, challenges, and innovative approaches in antibacterial drug development

Aiswarya M. Rajesh ... Rambabu Dandela

Published: January 26, 2025 Explor Drug Sci. 2025;3:100887

DOI: https://doi.org/10.37349/eds.2025.100887

Full Text PDF

20423 437 5

Open Access Editorial

Drug discovery: a multifactorial ecosystem

Fernando Albericio

Published: January 01, 2023 Explor Drug Sci. 2023;1:1–5

DOI: https://doi.org/10.37349/eds.2022.00001

Full Text PDF

20041 139 0

Open Access Review

Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review

Yethindra Vityala ... Krishna Chaitanya Meduri

Published: September 30, 2024 Explor Drug Sci. 2024;2:666–676

DOI: https://doi.org/10.37349/eds.2024.00067

Full Text PDF

19635 124 1

Open Access Review

Antimicrobial peptides: structure, function, mechanism of action and therapeutic applications in human diseases

Rahul Dilawari ... Neha Parmar

Published: May 09, 2025 Explor Drug Sci. 2025;3:1008110

DOI: https://doi.org/10.37349/eds.2025.1008110

Full Text PDF

19140 433 6

Open Access Review

Lutein and inflammation: a comprehensive review of its mechanisms of action

Paradentavida Prathyusha ... Edakkadath R. Sindhu

Published: January 25, 2025 Explor Drug Sci. 2025;3:100885

DOI: https://doi.org/10.37349/eds.2025.100885

This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer

Full Text PDF

18676 309 20